Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
A study conducted in Australia treated people attending a syringe services program.
The CDC has released a new hepatitis A surveillance report.
This is compared with providing people who inject drugs with hep C drugs to take independently.
The nation has provided unrestricted access to hepatitis C treatment since 2016.
This is according to two studies of real-world use of the hepatitis C regimen.
This finding is from a program that sought to provide blanket treatment to Iceland’s hep C population.
A new meta-analysis finds this population has a high success rate on hepatitis C therapy.
Researchers reviewed numerous studies to inform their detailed tips for better engaging people who inject opioid drugs in hepatitis C care.
After a reformulated version of the opioid painkiller hit the market in 2010, some with opioid use disorder migrated from pills to heroin.
A trio of British studies projected the impact of programs that provide clean injection-drug materials to people who inject drugs.
Existing federal law could permit prisons to negotiate a 90 percent–plus discount—without scaring off pharma.
Researchers say given the many associated downsides and risks, opioids should not be a first choice for chronic noncancer pain.
A recent survey of such sites found high rates of hepatitis C among patrons, but treatment for the virus was rarely offered on-site.
Researchers analyzed data resulting from a uniform hepatitis C testing policy in Washington state’s correctional facilities.
The generally false presumption that they won’t adhere to the regimen is often used to deny coverage for hep C medications.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.